- 首頁
- App 分析
- IHS Remote Monitoring
- IHS Remote Monitoring Vs. Impilo Patient
IHS Remote Monitoring 與 Impilo Patient 使用情況與統計
Infinite Health Services, LLC proudly presents its state-of-the-art Remote Theraputic Monitoring (RTM) app, designed to revolutionize the way patients manage their health. Our app is meticulously crafted to cater to the needs of both patients and healthcare providers, ensuring seamless and efficient health monitoring.
Key Features:
Real-Time Health Monitoring: The app allows patients to continuously monitor their Pain. This real-time data is instantly shared with healthcare providers for immediate analysis and intervention if necessary.
This app is only for monitoring purposes and patients have to get a medical consultation from the health care provider or the physician to make any medical decisions
- Apple App Store
- 免費版
- 健康與健身
商店排名
- -
The Impilo Patient App is an essential tool for patients participating in Impilo's remote healthcare services. This app allows you to easily access and monitor your vital health information from the comfort of your own home.
Key Features:
- View your vital sign readings
- Access your medical device information
- Find support information quickly
Designed exclusively for Impilo patients, this app seamlessly integrates with our comprehensive remote healthcare services. It provides a user-friendly interface to help you stay informed about your health status and manage your care more effectively.
Please note: This app is intended for use only by patients who have been specifically instructed to download it as part of their care program with Impilo. It is not for general public use.
Available for iPhone. Free to download for Impilo patients.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
IHS Remote Monitoring與 Impilo Patient 比較排名
比較過去 28 天的 IHS Remote Monitoring 排名趨勢與 Impilo Patient
排名
無可用數據
各國 IHS Remote Monitoring vs. Impilo Patient 排名比較
比較過去 28 天的 IHS Remote Monitoring 排名趨勢與 Impilo Patient
無可顯示數據
使用我們的免費試用版,與所有網站進行比較
IHS Remote Monitoring VS.
Impilo Patient
12月 14, 2024